Global Budesonide Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031
According to our (Global Info Research) latest study, the global Budesonide market size was valued at US$ 8985 million in 2024 and is forecast to a readjusted size of USD 11120 million by 2031 with a CAGR of 3.1% during review period.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
This report is a detailed and comprehensive analysis for global Budesonide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Budesonide market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Budesonide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Budesonide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Budesonide market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/K Units), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Budesonide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Budesonide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Budesonide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Budesonide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Budesonide, with price, sales quantity, revenue, and global market share of Budesonide from 2020 to 2025.
Chapter 3, the Budesonide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Budesonide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Budesonide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Budesonide.
Chapter 14 and 15, to describe Budesonide sales channel, distributors, customers, research findings and conclusion.
Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn's disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
North America is the largest market with about 36% revenue market share. Followed by Asia-Pacific and Europe, accounting for about 60% revenue market share.
The key players are AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, Lunan Better Pharma, Shanghai Sine Promod etc. AstraZeneca is the largest manufacturer with about 56% revenue market share.
This report is a detailed and comprehensive analysis for global Budesonide market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Budesonide market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Budesonide market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Budesonide market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031
Global Budesonide market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/K Units), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Budesonide
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Budesonide market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation, Cipla, Synmosa Biopharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Budesonide market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Injectable Suspension
- Aerosols
- Inhalation Powder
- Tablet and Capsule
- Respiratory Disease Treatment
- Nose Disease Treatment
- Inflammatory Bowel Disease Treatment
- Others
- AstraZeneca
- Teva
- Mylan
- Sandoz
- Cosmo Pharmaceuticals
- Salix
- Chiesi Farmaceutici
- Orion Corporation
- Cipla
- Synmosa Biopharma
- Lunan Better Pharma
- Shanghai Sine Promod
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Budesonide product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Budesonide, with price, sales quantity, revenue, and global market share of Budesonide from 2020 to 2025.
Chapter 3, the Budesonide competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Budesonide breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Budesonide market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Budesonide.
Chapter 14 and 15, to describe Budesonide sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Budesonide Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Injectable Suspension
1.3.3 Aerosols
1.3.4 Inhalation Powder
1.3.5 Tablet and Capsule
1.4 Market Analysis by Application
1.4.1 Overview: Global Budesonide Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Respiratory Disease Treatment
1.4.3 Nose Disease Treatment
1.4.4 Inflammatory Bowel Disease Treatment
1.4.5 Others
1.5 Global Budesonide Market Size & Forecast
1.5.1 Global Budesonide Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Budesonide Sales Quantity (2020-2031)
1.5.3 Global Budesonide Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Budesonide Product and Services
2.1.4 AstraZeneca Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Budesonide Product and Services
2.2.4 Teva Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Teva Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Budesonide Product and Services
2.3.4 Mylan Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mylan Recent Developments/Updates
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Budesonide Product and Services
2.4.4 Sandoz Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sandoz Recent Developments/Updates
2.5 Cosmo Pharmaceuticals
2.5.1 Cosmo Pharmaceuticals Details
2.5.2 Cosmo Pharmaceuticals Major Business
2.5.3 Cosmo Pharmaceuticals Budesonide Product and Services
2.5.4 Cosmo Pharmaceuticals Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.6 Salix
2.6.1 Salix Details
2.6.2 Salix Major Business
2.6.3 Salix Budesonide Product and Services
2.6.4 Salix Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Salix Recent Developments/Updates
2.7 Chiesi Farmaceutici
2.7.1 Chiesi Farmaceutici Details
2.7.2 Chiesi Farmaceutici Major Business
2.7.3 Chiesi Farmaceutici Budesonide Product and Services
2.7.4 Chiesi Farmaceutici Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Chiesi Farmaceutici Recent Developments/Updates
2.8 Orion Corporation
2.8.1 Orion Corporation Details
2.8.2 Orion Corporation Major Business
2.8.3 Orion Corporation Budesonide Product and Services
2.8.4 Orion Corporation Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Orion Corporation Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Budesonide Product and Services
2.9.4 Cipla Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Cipla Recent Developments/Updates
2.10 Synmosa Biopharma
2.10.1 Synmosa Biopharma Details
2.10.2 Synmosa Biopharma Major Business
2.10.3 Synmosa Biopharma Budesonide Product and Services
2.10.4 Synmosa Biopharma Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Synmosa Biopharma Recent Developments/Updates
2.11 Lunan Better Pharma
2.11.1 Lunan Better Pharma Details
2.11.2 Lunan Better Pharma Major Business
2.11.3 Lunan Better Pharma Budesonide Product and Services
2.11.4 Lunan Better Pharma Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Lunan Better Pharma Recent Developments/Updates
2.12 Shanghai Sine Promod
2.12.1 Shanghai Sine Promod Details
2.12.2 Shanghai Sine Promod Major Business
2.12.3 Shanghai Sine Promod Budesonide Product and Services
2.12.4 Shanghai Sine Promod Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Shanghai Sine Promod Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BUDESONIDE BY MANUFACTURER
3.1 Global Budesonide Sales Quantity by Manufacturer (2020-2025)
3.2 Global Budesonide Revenue by Manufacturer (2020-2025)
3.3 Global Budesonide Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Budesonide by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Budesonide Manufacturer Market Share in 2024
3.4.3 Top 6 Budesonide Manufacturer Market Share in 2024
3.5 Budesonide Market: Overall Company Footprint Analysis
3.5.1 Budesonide Market: Region Footprint
3.5.2 Budesonide Market: Company Product Type Footprint
3.5.3 Budesonide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Budesonide Market Size by Region
4.1.1 Global Budesonide Sales Quantity by Region (2020-2031)
4.1.2 Global Budesonide Consumption Value by Region (2020-2031)
4.1.3 Global Budesonide Average Price by Region (2020-2031)
4.2 North America Budesonide Consumption Value (2020-2031)
4.3 Europe Budesonide Consumption Value (2020-2031)
4.4 Asia-Pacific Budesonide Consumption Value (2020-2031)
4.5 South America Budesonide Consumption Value (2020-2031)
4.6 Middle East & Africa Budesonide Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Budesonide Sales Quantity by Type (2020-2031)
5.2 Global Budesonide Consumption Value by Type (2020-2031)
5.3 Global Budesonide Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Budesonide Sales Quantity by Application (2020-2031)
6.2 Global Budesonide Consumption Value by Application (2020-2031)
6.3 Global Budesonide Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Budesonide Sales Quantity by Type (2020-2031)
7.2 North America Budesonide Sales Quantity by Application (2020-2031)
7.3 North America Budesonide Market Size by Country
7.3.1 North America Budesonide Sales Quantity by Country (2020-2031)
7.3.2 North America Budesonide Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Budesonide Sales Quantity by Type (2020-2031)
8.2 Europe Budesonide Sales Quantity by Application (2020-2031)
8.3 Europe Budesonide Market Size by Country
8.3.1 Europe Budesonide Sales Quantity by Country (2020-2031)
8.3.2 Europe Budesonide Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Budesonide Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Budesonide Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Budesonide Market Size by Region
9.3.1 Asia-Pacific Budesonide Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Budesonide Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Budesonide Sales Quantity by Type (2020-2031)
10.2 South America Budesonide Sales Quantity by Application (2020-2031)
10.3 South America Budesonide Market Size by Country
10.3.1 South America Budesonide Sales Quantity by Country (2020-2031)
10.3.2 South America Budesonide Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Budesonide Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Budesonide Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Budesonide Market Size by Country
11.3.1 Middle East & Africa Budesonide Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Budesonide Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Budesonide Market Drivers
12.2 Budesonide Market Restraints
12.3 Budesonide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Budesonide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Budesonide
13.3 Budesonide Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Budesonide Typical Distributors
14.3 Budesonide Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Budesonide Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Injectable Suspension
1.3.3 Aerosols
1.3.4 Inhalation Powder
1.3.5 Tablet and Capsule
1.4 Market Analysis by Application
1.4.1 Overview: Global Budesonide Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Respiratory Disease Treatment
1.4.3 Nose Disease Treatment
1.4.4 Inflammatory Bowel Disease Treatment
1.4.5 Others
1.5 Global Budesonide Market Size & Forecast
1.5.1 Global Budesonide Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Budesonide Sales Quantity (2020-2031)
1.5.3 Global Budesonide Average Price (2020-2031)
2 MANUFACTURERS PROFILES
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Budesonide Product and Services
2.1.4 AstraZeneca Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.1.5 AstraZeneca Recent Developments/Updates
2.2 Teva
2.2.1 Teva Details
2.2.2 Teva Major Business
2.2.3 Teva Budesonide Product and Services
2.2.4 Teva Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.2.5 Teva Recent Developments/Updates
2.3 Mylan
2.3.1 Mylan Details
2.3.2 Mylan Major Business
2.3.3 Mylan Budesonide Product and Services
2.3.4 Mylan Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.3.5 Mylan Recent Developments/Updates
2.4 Sandoz
2.4.1 Sandoz Details
2.4.2 Sandoz Major Business
2.4.3 Sandoz Budesonide Product and Services
2.4.4 Sandoz Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.4.5 Sandoz Recent Developments/Updates
2.5 Cosmo Pharmaceuticals
2.5.1 Cosmo Pharmaceuticals Details
2.5.2 Cosmo Pharmaceuticals Major Business
2.5.3 Cosmo Pharmaceuticals Budesonide Product and Services
2.5.4 Cosmo Pharmaceuticals Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.5.5 Cosmo Pharmaceuticals Recent Developments/Updates
2.6 Salix
2.6.1 Salix Details
2.6.2 Salix Major Business
2.6.3 Salix Budesonide Product and Services
2.6.4 Salix Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.6.5 Salix Recent Developments/Updates
2.7 Chiesi Farmaceutici
2.7.1 Chiesi Farmaceutici Details
2.7.2 Chiesi Farmaceutici Major Business
2.7.3 Chiesi Farmaceutici Budesonide Product and Services
2.7.4 Chiesi Farmaceutici Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.7.5 Chiesi Farmaceutici Recent Developments/Updates
2.8 Orion Corporation
2.8.1 Orion Corporation Details
2.8.2 Orion Corporation Major Business
2.8.3 Orion Corporation Budesonide Product and Services
2.8.4 Orion Corporation Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.8.5 Orion Corporation Recent Developments/Updates
2.9 Cipla
2.9.1 Cipla Details
2.9.2 Cipla Major Business
2.9.3 Cipla Budesonide Product and Services
2.9.4 Cipla Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.9.5 Cipla Recent Developments/Updates
2.10 Synmosa Biopharma
2.10.1 Synmosa Biopharma Details
2.10.2 Synmosa Biopharma Major Business
2.10.3 Synmosa Biopharma Budesonide Product and Services
2.10.4 Synmosa Biopharma Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.10.5 Synmosa Biopharma Recent Developments/Updates
2.11 Lunan Better Pharma
2.11.1 Lunan Better Pharma Details
2.11.2 Lunan Better Pharma Major Business
2.11.3 Lunan Better Pharma Budesonide Product and Services
2.11.4 Lunan Better Pharma Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.11.5 Lunan Better Pharma Recent Developments/Updates
2.12 Shanghai Sine Promod
2.12.1 Shanghai Sine Promod Details
2.12.2 Shanghai Sine Promod Major Business
2.12.3 Shanghai Sine Promod Budesonide Product and Services
2.12.4 Shanghai Sine Promod Budesonide Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2020-2025)
2.12.5 Shanghai Sine Promod Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: BUDESONIDE BY MANUFACTURER
3.1 Global Budesonide Sales Quantity by Manufacturer (2020-2025)
3.2 Global Budesonide Revenue by Manufacturer (2020-2025)
3.3 Global Budesonide Average Price by Manufacturer (2020-2025)
3.4 Market Share Analysis (2024)
3.4.1 Producer Shipments of Budesonide by Manufacturer Revenue ($MM) and Market Share (%): 2024
3.4.2 Top 3 Budesonide Manufacturer Market Share in 2024
3.4.3 Top 6 Budesonide Manufacturer Market Share in 2024
3.5 Budesonide Market: Overall Company Footprint Analysis
3.5.1 Budesonide Market: Region Footprint
3.5.2 Budesonide Market: Company Product Type Footprint
3.5.3 Budesonide Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Budesonide Market Size by Region
4.1.1 Global Budesonide Sales Quantity by Region (2020-2031)
4.1.2 Global Budesonide Consumption Value by Region (2020-2031)
4.1.3 Global Budesonide Average Price by Region (2020-2031)
4.2 North America Budesonide Consumption Value (2020-2031)
4.3 Europe Budesonide Consumption Value (2020-2031)
4.4 Asia-Pacific Budesonide Consumption Value (2020-2031)
4.5 South America Budesonide Consumption Value (2020-2031)
4.6 Middle East & Africa Budesonide Consumption Value (2020-2031)
5 MARKET SEGMENT BY TYPE
5.1 Global Budesonide Sales Quantity by Type (2020-2031)
5.2 Global Budesonide Consumption Value by Type (2020-2031)
5.3 Global Budesonide Average Price by Type (2020-2031)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Budesonide Sales Quantity by Application (2020-2031)
6.2 Global Budesonide Consumption Value by Application (2020-2031)
6.3 Global Budesonide Average Price by Application (2020-2031)
7 NORTH AMERICA
7.1 North America Budesonide Sales Quantity by Type (2020-2031)
7.2 North America Budesonide Sales Quantity by Application (2020-2031)
7.3 North America Budesonide Market Size by Country
7.3.1 North America Budesonide Sales Quantity by Country (2020-2031)
7.3.2 North America Budesonide Consumption Value by Country (2020-2031)
7.3.3 United States Market Size and Forecast (2020-2031)
7.3.4 Canada Market Size and Forecast (2020-2031)
7.3.5 Mexico Market Size and Forecast (2020-2031)
8 EUROPE
8.1 Europe Budesonide Sales Quantity by Type (2020-2031)
8.2 Europe Budesonide Sales Quantity by Application (2020-2031)
8.3 Europe Budesonide Market Size by Country
8.3.1 Europe Budesonide Sales Quantity by Country (2020-2031)
8.3.2 Europe Budesonide Consumption Value by Country (2020-2031)
8.3.3 Germany Market Size and Forecast (2020-2031)
8.3.4 France Market Size and Forecast (2020-2031)
8.3.5 United Kingdom Market Size and Forecast (2020-2031)
8.3.6 Russia Market Size and Forecast (2020-2031)
8.3.7 Italy Market Size and Forecast (2020-2031)
9 ASIA-PACIFIC
9.1 Asia-Pacific Budesonide Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Budesonide Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Budesonide Market Size by Region
9.3.1 Asia-Pacific Budesonide Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Budesonide Consumption Value by Region (2020-2031)
9.3.3 China Market Size and Forecast (2020-2031)
9.3.4 Japan Market Size and Forecast (2020-2031)
9.3.5 South Korea Market Size and Forecast (2020-2031)
9.3.6 India Market Size and Forecast (2020-2031)
9.3.7 Southeast Asia Market Size and Forecast (2020-2031)
9.3.8 Australia Market Size and Forecast (2020-2031)
10 SOUTH AMERICA
10.1 South America Budesonide Sales Quantity by Type (2020-2031)
10.2 South America Budesonide Sales Quantity by Application (2020-2031)
10.3 South America Budesonide Market Size by Country
10.3.1 South America Budesonide Sales Quantity by Country (2020-2031)
10.3.2 South America Budesonide Consumption Value by Country (2020-2031)
10.3.3 Brazil Market Size and Forecast (2020-2031)
10.3.4 Argentina Market Size and Forecast (2020-2031)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Budesonide Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Budesonide Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Budesonide Market Size by Country
11.3.1 Middle East & Africa Budesonide Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Budesonide Consumption Value by Country (2020-2031)
11.3.3 Turkey Market Size and Forecast (2020-2031)
11.3.4 Egypt Market Size and Forecast (2020-2031)
11.3.5 Saudi Arabia Market Size and Forecast (2020-2031)
11.3.6 South Africa Market Size and Forecast (2020-2031)
12 MARKET DYNAMICS
12.1 Budesonide Market Drivers
12.2 Budesonide Market Restraints
12.3 Budesonide Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Budesonide and Key Manufacturers
13.2 Manufacturing Costs Percentage of Budesonide
13.3 Budesonide Production Process
13.4 Industry Value Chain Analysis
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Budesonide Typical Distributors
14.3 Budesonide Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Budesonide Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Budesonide Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Budesonide Product and Services
Table 6. AstraZeneca Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Budesonide Product and Services
Table 11. Teva Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Teva Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Budesonide Product and Services
Table 16. Mylan Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Mylan Recent Developments/Updates
Table 18. Sandoz Basic Information, Manufacturing Base and Competitors
Table 19. Sandoz Major Business
Table 20. Sandoz Budesonide Product and Services
Table 21. Sandoz Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Sandoz Recent Developments/Updates
Table 23. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Cosmo Pharmaceuticals Major Business
Table 25. Cosmo Pharmaceuticals Budesonide Product and Services
Table 26. Cosmo Pharmaceuticals Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Cosmo Pharmaceuticals Recent Developments/Updates
Table 28. Salix Basic Information, Manufacturing Base and Competitors
Table 29. Salix Major Business
Table 30. Salix Budesonide Product and Services
Table 31. Salix Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Salix Recent Developments/Updates
Table 33. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 34. Chiesi Farmaceutici Major Business
Table 35. Chiesi Farmaceutici Budesonide Product and Services
Table 36. Chiesi Farmaceutici Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Chiesi Farmaceutici Recent Developments/Updates
Table 38. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Orion Corporation Major Business
Table 40. Orion Corporation Budesonide Product and Services
Table 41. Orion Corporation Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Orion Corporation Recent Developments/Updates
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Major Business
Table 45. Cipla Budesonide Product and Services
Table 46. Cipla Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Cipla Recent Developments/Updates
Table 48. Synmosa Biopharma Basic Information, Manufacturing Base and Competitors
Table 49. Synmosa Biopharma Major Business
Table 50. Synmosa Biopharma Budesonide Product and Services
Table 51. Synmosa Biopharma Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Synmosa Biopharma Recent Developments/Updates
Table 53. Lunan Better Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Lunan Better Pharma Major Business
Table 55. Lunan Better Pharma Budesonide Product and Services
Table 56. Lunan Better Pharma Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Lunan Better Pharma Recent Developments/Updates
Table 58. Shanghai Sine Promod Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Sine Promod Major Business
Table 60. Shanghai Sine Promod Budesonide Product and Services
Table 61. Shanghai Sine Promod Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Shanghai Sine Promod Recent Developments/Updates
Table 63. Global Budesonide Sales Quantity by Manufacturer (2020-2025) & (M Units)
Table 64. Global Budesonide Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global Budesonide Average Price by Manufacturer (2020-2025) & (USD/K Units)
Table 66. Market Position of Manufacturers in Budesonide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and Budesonide Production Site of Key Manufacturer
Table 68. Budesonide Market: Company Product Type Footprint
Table 69. Budesonide Market: Company Product Application Footprint
Table 70. Budesonide New Market Entrants and Barriers to Market Entry
Table 71. Budesonide Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Budesonide Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global Budesonide Sales Quantity by Region (2020-2025) & (M Units)
Table 74. Global Budesonide Sales Quantity by Region (2026-2031) & (M Units)
Table 75. Global Budesonide Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global Budesonide Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global Budesonide Average Price by Region (2020-2025) & (USD/K Units)
Table 78. Global Budesonide Average Price by Region (2026-2031) & (USD/K Units)
Table 79. Global Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 80. Global Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 81. Global Budesonide Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global Budesonide Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global Budesonide Average Price by Type (2020-2025) & (USD/K Units)
Table 84. Global Budesonide Average Price by Type (2026-2031) & (USD/K Units)
Table 85. Global Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 86. Global Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 87. Global Budesonide Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global Budesonide Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global Budesonide Average Price by Application (2020-2025) & (USD/K Units)
Table 90. Global Budesonide Average Price by Application (2026-2031) & (USD/K Units)
Table 91. North America Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 92. North America Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 93. North America Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 94. North America Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 95. North America Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 96. North America Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 97. North America Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 100. Europe Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 101. Europe Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 102. Europe Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 103. Europe Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 104. Europe Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 105. Europe Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 108. Asia-Pacific Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 109. Asia-Pacific Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 110. Asia-Pacific Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 111. Asia-Pacific Budesonide Sales Quantity by Region (2020-2025) & (M Units)
Table 112. Asia-Pacific Budesonide Sales Quantity by Region (2026-2031) & (M Units)
Table 113. Asia-Pacific Budesonide Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific Budesonide Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 116. South America Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 117. South America Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 118. South America Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 119. South America Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 120. South America Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 121. South America Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 124. Middle East & Africa Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 125. Middle East & Africa Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 126. Middle East & Africa Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 127. Middle East & Africa Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 128. Middle East & Africa Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 129. Middle East & Africa Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 131. Budesonide Raw Material
Table 132. Key Manufacturers of Budesonide Raw Materials
Table 133. Budesonide Typical Distributors
Table 134. Budesonide Typical Customers
Table 1. Global Budesonide Consumption Value by Type, (USD Million), 2020 & 2024 & 2031
Table 2. Global Budesonide Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Budesonide Product and Services
Table 6. AstraZeneca Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 7. AstraZeneca Recent Developments/Updates
Table 8. Teva Basic Information, Manufacturing Base and Competitors
Table 9. Teva Major Business
Table 10. Teva Budesonide Product and Services
Table 11. Teva Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 12. Teva Recent Developments/Updates
Table 13. Mylan Basic Information, Manufacturing Base and Competitors
Table 14. Mylan Major Business
Table 15. Mylan Budesonide Product and Services
Table 16. Mylan Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 17. Mylan Recent Developments/Updates
Table 18. Sandoz Basic Information, Manufacturing Base and Competitors
Table 19. Sandoz Major Business
Table 20. Sandoz Budesonide Product and Services
Table 21. Sandoz Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 22. Sandoz Recent Developments/Updates
Table 23. Cosmo Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Cosmo Pharmaceuticals Major Business
Table 25. Cosmo Pharmaceuticals Budesonide Product and Services
Table 26. Cosmo Pharmaceuticals Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 27. Cosmo Pharmaceuticals Recent Developments/Updates
Table 28. Salix Basic Information, Manufacturing Base and Competitors
Table 29. Salix Major Business
Table 30. Salix Budesonide Product and Services
Table 31. Salix Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 32. Salix Recent Developments/Updates
Table 33. Chiesi Farmaceutici Basic Information, Manufacturing Base and Competitors
Table 34. Chiesi Farmaceutici Major Business
Table 35. Chiesi Farmaceutici Budesonide Product and Services
Table 36. Chiesi Farmaceutici Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 37. Chiesi Farmaceutici Recent Developments/Updates
Table 38. Orion Corporation Basic Information, Manufacturing Base and Competitors
Table 39. Orion Corporation Major Business
Table 40. Orion Corporation Budesonide Product and Services
Table 41. Orion Corporation Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 42. Orion Corporation Recent Developments/Updates
Table 43. Cipla Basic Information, Manufacturing Base and Competitors
Table 44. Cipla Major Business
Table 45. Cipla Budesonide Product and Services
Table 46. Cipla Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 47. Cipla Recent Developments/Updates
Table 48. Synmosa Biopharma Basic Information, Manufacturing Base and Competitors
Table 49. Synmosa Biopharma Major Business
Table 50. Synmosa Biopharma Budesonide Product and Services
Table 51. Synmosa Biopharma Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 52. Synmosa Biopharma Recent Developments/Updates
Table 53. Lunan Better Pharma Basic Information, Manufacturing Base and Competitors
Table 54. Lunan Better Pharma Major Business
Table 55. Lunan Better Pharma Budesonide Product and Services
Table 56. Lunan Better Pharma Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 57. Lunan Better Pharma Recent Developments/Updates
Table 58. Shanghai Sine Promod Basic Information, Manufacturing Base and Competitors
Table 59. Shanghai Sine Promod Major Business
Table 60. Shanghai Sine Promod Budesonide Product and Services
Table 61. Shanghai Sine Promod Budesonide Sales Quantity (M Units), Average Price (USD/K Units), Revenue (USD Million), Gross Margin and Market Share (2020-2025)
Table 62. Shanghai Sine Promod Recent Developments/Updates
Table 63. Global Budesonide Sales Quantity by Manufacturer (2020-2025) & (M Units)
Table 64. Global Budesonide Revenue by Manufacturer (2020-2025) & (USD Million)
Table 65. Global Budesonide Average Price by Manufacturer (2020-2025) & (USD/K Units)
Table 66. Market Position of Manufacturers in Budesonide, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2024
Table 67. Head Office and Budesonide Production Site of Key Manufacturer
Table 68. Budesonide Market: Company Product Type Footprint
Table 69. Budesonide Market: Company Product Application Footprint
Table 70. Budesonide New Market Entrants and Barriers to Market Entry
Table 71. Budesonide Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Budesonide Consumption Value by Region (2020-2024-2031) & (USD Million) & CAGR
Table 73. Global Budesonide Sales Quantity by Region (2020-2025) & (M Units)
Table 74. Global Budesonide Sales Quantity by Region (2026-2031) & (M Units)
Table 75. Global Budesonide Consumption Value by Region (2020-2025) & (USD Million)
Table 76. Global Budesonide Consumption Value by Region (2026-2031) & (USD Million)
Table 77. Global Budesonide Average Price by Region (2020-2025) & (USD/K Units)
Table 78. Global Budesonide Average Price by Region (2026-2031) & (USD/K Units)
Table 79. Global Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 80. Global Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 81. Global Budesonide Consumption Value by Type (2020-2025) & (USD Million)
Table 82. Global Budesonide Consumption Value by Type (2026-2031) & (USD Million)
Table 83. Global Budesonide Average Price by Type (2020-2025) & (USD/K Units)
Table 84. Global Budesonide Average Price by Type (2026-2031) & (USD/K Units)
Table 85. Global Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 86. Global Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 87. Global Budesonide Consumption Value by Application (2020-2025) & (USD Million)
Table 88. Global Budesonide Consumption Value by Application (2026-2031) & (USD Million)
Table 89. Global Budesonide Average Price by Application (2020-2025) & (USD/K Units)
Table 90. Global Budesonide Average Price by Application (2026-2031) & (USD/K Units)
Table 91. North America Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 92. North America Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 93. North America Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 94. North America Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 95. North America Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 96. North America Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 97. North America Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 98. North America Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 99. Europe Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 100. Europe Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 101. Europe Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 102. Europe Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 103. Europe Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 104. Europe Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 105. Europe Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 106. Europe Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 107. Asia-Pacific Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 108. Asia-Pacific Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 109. Asia-Pacific Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 110. Asia-Pacific Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 111. Asia-Pacific Budesonide Sales Quantity by Region (2020-2025) & (M Units)
Table 112. Asia-Pacific Budesonide Sales Quantity by Region (2026-2031) & (M Units)
Table 113. Asia-Pacific Budesonide Consumption Value by Region (2020-2025) & (USD Million)
Table 114. Asia-Pacific Budesonide Consumption Value by Region (2026-2031) & (USD Million)
Table 115. South America Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 116. South America Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 117. South America Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 118. South America Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 119. South America Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 120. South America Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 121. South America Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 122. South America Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 123. Middle East & Africa Budesonide Sales Quantity by Type (2020-2025) & (M Units)
Table 124. Middle East & Africa Budesonide Sales Quantity by Type (2026-2031) & (M Units)
Table 125. Middle East & Africa Budesonide Sales Quantity by Application (2020-2025) & (M Units)
Table 126. Middle East & Africa Budesonide Sales Quantity by Application (2026-2031) & (M Units)
Table 127. Middle East & Africa Budesonide Sales Quantity by Country (2020-2025) & (M Units)
Table 128. Middle East & Africa Budesonide Sales Quantity by Country (2026-2031) & (M Units)
Table 129. Middle East & Africa Budesonide Consumption Value by Country (2020-2025) & (USD Million)
Table 130. Middle East & Africa Budesonide Consumption Value by Country (2026-2031) & (USD Million)
Table 131. Budesonide Raw Material
Table 132. Key Manufacturers of Budesonide Raw Materials
Table 133. Budesonide Typical Distributors
Table 134. Budesonide Typical Customers
LIST OF FIGURES
Figure 1. Budesonide Picture
Figure 2. Global Budesonide Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Budesonide Revenue Market Share by Type in 2024
Figure 4. Injectable Suspension Examples
Figure 5. Aerosols Examples
Figure 6. Inhalation Powder Examples
Figure 7. Tablet and Capsule Examples
Figure 8. Global Budesonide Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Budesonide Revenue Market Share by Application in 2024
Figure 10. Respiratory Disease Treatment Examples
Figure 11. Nose Disease Treatment Examples
Figure 12. Inflammatory Bowel Disease Treatment Examples
Figure 13. Others Examples
Figure 14. Global Budesonide Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Budesonide Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Budesonide Sales Quantity (2020-2031) & (M Units)
Figure 17. Global Budesonide Price (2020-2031) & (USD/K Units)
Figure 18. Global Budesonide Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Budesonide Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Budesonide by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 Budesonide Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 Budesonide Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Budesonide Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Budesonide Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global Budesonide Consumption Value Market Share by Type (2020-2031)
Figure 32. Global Budesonide Average Price by Type (2020-2031) & (USD/K Units)
Figure 33. Global Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Budesonide Revenue Market Share by Application (2020-2031)
Figure 35. Global Budesonide Average Price by Application (2020-2031) & (USD/K Units)
Figure 36. North America Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 48. France Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Budesonide Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Budesonide Consumption Value Market Share by Region (2020-2031)
Figure 56. China Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 59. India Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 76. Budesonide Market Drivers
Figure 77. Budesonide Market Restraints
Figure 78. Budesonide Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Budesonide in 2024
Figure 81. Manufacturing Process Analysis of Budesonide
Figure 82. Budesonide Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
Figure 1. Budesonide Picture
Figure 2. Global Budesonide Revenue by Type, (USD Million), 2020 & 2024 & 2031
Figure 3. Global Budesonide Revenue Market Share by Type in 2024
Figure 4. Injectable Suspension Examples
Figure 5. Aerosols Examples
Figure 6. Inhalation Powder Examples
Figure 7. Tablet and Capsule Examples
Figure 8. Global Budesonide Consumption Value by Application, (USD Million), 2020 & 2024 & 2031
Figure 9. Global Budesonide Revenue Market Share by Application in 2024
Figure 10. Respiratory Disease Treatment Examples
Figure 11. Nose Disease Treatment Examples
Figure 12. Inflammatory Bowel Disease Treatment Examples
Figure 13. Others Examples
Figure 14. Global Budesonide Consumption Value, (USD Million): 2020 & 2024 & 2031
Figure 15. Global Budesonide Consumption Value and Forecast (2020-2031) & (USD Million)
Figure 16. Global Budesonide Sales Quantity (2020-2031) & (M Units)
Figure 17. Global Budesonide Price (2020-2031) & (USD/K Units)
Figure 18. Global Budesonide Sales Quantity Market Share by Manufacturer in 2024
Figure 19. Global Budesonide Revenue Market Share by Manufacturer in 2024
Figure 20. Producer Shipments of Budesonide by Manufacturer Sales ($MM) and Market Share (%): 2024
Figure 21. Top 3 Budesonide Manufacturer (Revenue) Market Share in 2024
Figure 22. Top 6 Budesonide Manufacturer (Revenue) Market Share in 2024
Figure 23. Global Budesonide Sales Quantity Market Share by Region (2020-2031)
Figure 24. Global Budesonide Consumption Value Market Share by Region (2020-2031)
Figure 25. North America Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 26. Europe Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 27. Asia-Pacific Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 28. South America Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 29. Middle East & Africa Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 30. Global Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 31. Global Budesonide Consumption Value Market Share by Type (2020-2031)
Figure 32. Global Budesonide Average Price by Type (2020-2031) & (USD/K Units)
Figure 33. Global Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 34. Global Budesonide Revenue Market Share by Application (2020-2031)
Figure 35. Global Budesonide Average Price by Application (2020-2031) & (USD/K Units)
Figure 36. North America Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 37. North America Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 38. North America Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 39. North America Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 40. United States Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 41. Canada Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 42. Mexico Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 43. Europe Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 44. Europe Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 45. Europe Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 46. Europe Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 47. Germany Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 48. France Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 49. United Kingdom Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 50. Russia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 51. Italy Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 52. Asia-Pacific Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 53. Asia-Pacific Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 54. Asia-Pacific Budesonide Sales Quantity Market Share by Region (2020-2031)
Figure 55. Asia-Pacific Budesonide Consumption Value Market Share by Region (2020-2031)
Figure 56. China Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 57. Japan Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 58. South Korea Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 59. India Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 60. Southeast Asia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 61. Australia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 62. South America Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 63. South America Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 64. South America Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 65. South America Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 66. Brazil Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 67. Argentina Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 68. Middle East & Africa Budesonide Sales Quantity Market Share by Type (2020-2031)
Figure 69. Middle East & Africa Budesonide Sales Quantity Market Share by Application (2020-2031)
Figure 70. Middle East & Africa Budesonide Sales Quantity Market Share by Country (2020-2031)
Figure 71. Middle East & Africa Budesonide Consumption Value Market Share by Country (2020-2031)
Figure 72. Turkey Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 73. Egypt Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 74. Saudi Arabia Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 75. South Africa Budesonide Consumption Value (2020-2031) & (USD Million)
Figure 76. Budesonide Market Drivers
Figure 77. Budesonide Market Restraints
Figure 78. Budesonide Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Budesonide in 2024
Figure 81. Manufacturing Process Analysis of Budesonide
Figure 82. Budesonide Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
